Discover a study comparing two types of treatment for bladder cancer, robot-assisted radical cystectomy and intracorporeal ...

Discover the trials that have shown why Predictive biomarkers are expected to play a pivotal role in further enhancing ...

Men who had radiotherapy to treat their prostate cancer were three times more likely to develop bladder cancer compared with ...

Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for ...

Adjuvant Opdivo showed a significant improvement in overall survival and disease-free survival for patients with high-risk ...

Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic ...

Nectin-4 antibody-drug conjugate (ADC) and checkpoint inhibitor combinations have represented a great advancement in the treatment of bladder cancer, but relapse and treatment-related toxicities ...

Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.

The following is a summary of “Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder ...

The "Bladder Cancer: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Bladder cancer (International Classification of Diseases, 10th Revision [ICD-10] codes ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand ...